Allogene Therapeutics Inc Cash Flow Reinvestment Rate

Latest as of March 2018: 63355.20x

Allogene Therapeutics Inc cash flow reinvestment rate. Allogene Therapeutics Inc (ALLO) has a Cash Flow Reinvestment Rate of 63355.20x as of March 2018, reinvesting $316.78 Million (capex $1.38 Million plus investments $-315.40 Million) from operating cash flow of $5.00K. See Allogene Therapeutics Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.

Reinvestment Rate

63355.20x
(Capex + Investments) / Operating CF

Total Reinvested

$316.78 Million
Capex + Investments

Operating Cash Flow

$5.00K
USD

Capital Expenditures

$1.38 Million
USD

Allogene Therapeutics Inc Cash Flow Reinvestment Rate by Year (None–None)

Allogene Therapeutics Inc cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Allogene Therapeutics Inc. For the full cash flow conversion analysis, see how efficiently does Allogene Therapeutics Inc generate cash.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow